oxidopamine has been researched along with Decerebrate Posturing in 12 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Excerpt | Relevance | Reference |
---|---|---|
"No protection against drug-induced arrhythmia or death was afforded by this procedure." | 5.27 | Does chlorpromazine produce cardiac arrhythmia via the central nervous system? ( Lathers, CM; Lipka, LJ; Roberts, J, 1988) |
"No protection against drug-induced arrhythmia or death was afforded by this procedure." | 1.27 | Does chlorpromazine produce cardiac arrhythmia via the central nervous system? ( Lathers, CM; Lipka, LJ; Roberts, J, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (50.00) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Luquin, N | 1 |
Mitrofanis, J | 1 |
Van der Werf, JF | 2 |
Sebens, JB | 2 |
Korf, J | 2 |
Van het Schip, F | 1 |
Kolibal-Pegher, S | 1 |
Edwards, DJ | 1 |
Meyers-Schoy, SA | 1 |
Vollmer, RR | 2 |
Moorman, SJ | 1 |
Whalen, LR | 1 |
Kobayashi, H | 1 |
Hasegawa, Y | 1 |
Ono, H | 1 |
Ono, M | 1 |
Satoh, T | 1 |
Konkol, RJ | 1 |
Wesselmann, U | 1 |
Karpus, WJ | 1 |
Leo, GL | 1 |
Killen, JA | 1 |
Roerig, DL | 1 |
Fluharty, SJ | 1 |
Meyers, SA | 1 |
McCann, MJ | 1 |
Zigmond, MJ | 1 |
Stricker, EM | 1 |
Fozard, JR | 1 |
Palfreyman, MG | 1 |
Robin, M | 1 |
Zreika, M | 1 |
Lai, YY | 1 |
Siegel, JM | 1 |
Wilson, WJ | 1 |
Lipka, LJ | 1 |
Lathers, CM | 1 |
Roberts, J | 1 |
12 other studies available for oxidopamine and Decerebrate Posturing
Article | Year |
---|---|
Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
Topics: Adrenergic Agents; Animals; Cell Count; Cell Death; Decerebrate State; Dopamine; Male; Neurons; Oxid | 2008 |
In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication.
Topics: Animals; Apomorphine; Cerebellum; Corpus Striatum; Decerebrate State; Hydroxydopamines; Kainic Acid; | 1984 |
Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
Topics: Animals; Butyrophenones; Cerebral Cortex; Corpus Striatum; Decerebrate State; Hydroxydopamines; Kain | 1984 |
Adrenal medullary adaptations and cardiovascular regulation after 6-hydroxydopamine treatment in rats.
Topics: Adrenal Medulla; Adrenalectomy; Animals; Behavior, Animal; Blood Pressure; Decerebrate State; Dopami | 1994 |
A model system to determine the effects of specific neurotransmitters on segmental reflexes in the spinal cord of the rat.
Topics: Animals; Clonidine; Decerebrate State; Dopamine; Electromyography; Electrophysiology; Female; Hindli | 1993 |
Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems.
Topics: Adrenergic alpha-2 Receptor Antagonists; Amitriptyline; Animals; Decerebrate State; Fenclonine; Male | 1996 |
Pharmacological studies on lappaconitine: possible interaction with endogenous noradrenergic and serotonergic pathways to induce antinociception.
Topics: 5,7-Dihydroxytryptamine; Aconitine; Afferent Pathways; Analgesics; Animals; Decerebrate State; Injec | 1992 |
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine.
Topics: Animals; Body Weight; Brain; Catecholamines; Cerebral Ventricles; Cisterna Magna; Decerebrate State; | 1990 |
Recovery of chronotropic responsiveness after systemic 6-hydroxydopamine treatment: studies in the pithed rat.
Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Blood Pressure; Catecholamines; Decerebrate State; | 1987 |
Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
Topics: Allylamine; Amines; Animals; Blood Pressure; Brain; Decerebrate State; Dose-Response Relationship, D | 1986 |
Effect of blood pressure on medial medulla-induced muscle atonia.
Topics: Adrenal Medulla; Animals; Blood Pressure; Brain Stem; Carotid Arteries; Cats; Decerebrate State; Den | 1987 |
Does chlorpromazine produce cardiac arrhythmia via the central nervous system?
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Central Nervous System; Chlorpromazine; Decereb | 1988 |